Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Sutro Biopharma Inc (NQ: STRO )

4.720 +0.260 (+5.83%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 2, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 484,264
Open 4.480
Bid (Size) 4.720 (3)
Ask (Size) 4.740 (2)
Prev. Close 4.460
Today's Range 4.410 - 4.730
52wk Range 3.330 - 8.720
Shares Outstanding 60,416,916
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why Monro Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers CaliberCos Inc. (NASDAQ: CWD) shares jumped 65.6% to $9.94 amid post-IPO volatility. 
Via Benzinga
Sutro Biopharma Earnings Perspective: Return On Capital Employed
 
Via Benzinga

Performance

YTD
-41.15%
-41.15%
1 Month
+2.61%
+2.61%
3 Month
-17.91%
-17.91%
6 Month
-36.39%
-36.39%
1 Year
+12.38%
+12.38%

More News

Read More
Where Sutro Biopharma Stands With Analysts
Via Benzinga
Super Micro Computer, Rayonier Advanced Materials And Some Other Big Stocks Moving Lower On Tuesday
Via Benzinga
Sutro Biopharma Posts Updated Data From Ovarian Cancer Candidate
Via Benzinga
Recap: Sutro Biopharma Q2 Earnings
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Why Investors Are Suddenly Excited About Vaxcyte
Via MarketBeat
Exposures COVID-19
Why Tricida Shares Dipped Around 95%; Here Are 73 Biggest Movers From Yesterday
Via Benzinga
Short Volatility Alert: Sutro Biopharma, Inc.
Via Benzinga
Avis Budget, Scholastic And Other Big Gainers From Monday
Via Benzinga
Sutro Biopharma Earnings Perspective: Return On Capital Employed
Via Benzinga
Daily Biotech Pulse: Teva's Opioids Settlement, Criminal Investigation Against Cassava, Durable Responses For IN8bio's Leukemia Therapy
Via Benzinga
Why Is Ceragon Networks Surging By 19%? 41 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
InflaRx Climbs More Than 40%, Here's 58 Biggest Movers From Yesterday
Via Benzinga
Markets Open Higher; US Goods Gap Narrows To $104.3B In May
Via Benzinga
Sutro Biopharma Stock Surges On Cancer Treatment Pact
Via Benzinga
The Daily Biotech Pulse: Kezar Life Surges On Positive Kidney Disease Trial Data, FDA Rejects Spero Therapeutics' Tebipenem, Graybug Reviews Strategic Alternatives
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
Why Is Kezar Life Sciences Surging By 78%? 25 Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
75 Biggest Movers From Yesterday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.